drugset
drugset / Trial / NCT04972383

Comparing Effect of Autologous Platelet-Rich Plasma Versus Hyaluronic Acid Treatment on Knee Osteoarthritis

NCT04972383 ↗

Phase 3 Completed 116 enrolled Kaohsiung Medical University Chung-Ho Memorial Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the efficacy and structural change of intraarticular single platelet-rich plasma(PRP) versus novel crosslinked Hyaluronic Acid(HA)(HyajointPlus) for the treatment of early stage knee osteoarthritis(OA). This was a prospective, double-blind, RCT with an allocation ratio of 1:1.

Timeline

Start
2017-11-07
Primary completion
2019-10-16
Completion
2019-10-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified 60 mg Other
Subject Platelet Rich Plasma Other / unclassified 4 ml Other

Indications

osteoarthritis, knee